Terms: = Kidney tumors AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
38 results:
1. Metabolic reprogramming of clear cell renal cell carcinoma.
Zhu H; Wang X; Lu S; Ou K
Front Endocrinol (Lausanne); 2023; 14():1195500. PubMed ID: 37347113
[TBL] [Abstract] [Full Text] [Related]
2. Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients.
Xu C; Liu W; Yin C; Li W; Liu J; Sheng W; Tang H; Li W; Zhang Q
Comput Math Methods Med; 2022; 2022():5676570. PubMed ID: 36226243
[TBL] [Abstract] [Full Text] [Related]
3. ELOVL2 promotes cancer progression by inhibiting cell apoptosis in renal cell carcinoma.
Tanaka K; Kandori S; Sakka S; Nitta S; Tanuma K; Shiga M; Nagumo Y; Negoro H; Kojima T; Mathis BJ; Shimazui T; Watanabe M; Sato TA; Miyamoto T; Matsuzaka T; Shimano H; Nishiyama H
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34841437
[TBL] [Abstract] [Full Text] [Related]
4. Renal Primitive Neuroectodermal Tumor With Inferior Vena Cava Thrombus: Case Series and Literature Review of a Rare but Challenging Entity.
Xu C; Sun Z; Xiao R; He W; Ma L
Clin Genitourin Cancer; 2021 Oct; 19(5):e273-e279. PubMed ID: 33941490
[TBL] [Abstract] [Full Text] [Related]
5. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract] [Full Text] [Related]
6. [Eosinophilic solid and cystic renal cell carcinoma with TSC2 gene mutations in children].
Yang WP; Chang KTE; Xu HY; Kuick CH; Ng EHQ; Huang H; Xiong F; Wu Y; Zeng ST; Fan JX; Loh XY
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):693-698. PubMed ID: 32610380
[No Abstract] [Full Text] [Related]
7. Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.
Wang Z; Cheng H; Qi L; Sui D
Mol Med Rep; 2020 Jul; 22(1):105-116. PubMed ID: 32377711
[TBL] [Abstract] [Full Text] [Related]
8. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
[TBL] [Abstract] [Full Text] [Related]
9. FABP5 is correlated with poor prognosis and promotes tumour cell growth and metastasis in clear cell renal cell carcinoma.
Wu G; Xu Y; Wang Q; Li J; Li L; Han C; Xia Q
Eur J Pharmacol; 2019 Nov; 862():172637. PubMed ID: 31491402
[TBL] [Abstract] [Full Text] [Related]
10. [Prognostic factors in renal cancer with venous thrombus survival analysis.].
Pascual-Fernández A; Calleja-Escudero J; Gómez de Segura C; Pesquera-Ortega L; Taylor J; Fajardo JA; González de Zárate J; Monllor-Gisbert J; Cortiñas-González JR
Arch Esp Urol; 2017 Jul; 70(6):570-578. PubMed ID: 28678010
[TBL] [Abstract] [Full Text] [Related]
11. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy.
Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179
[TBL] [Abstract] [Full Text] [Related]
12. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
Reiter M; Eckhardt I; Haferkamp A; Fulda S
Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
[TBL] [Abstract] [Full Text] [Related]
13. Dialysis-Requiring Acute kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study.
Carlson N; Hommel K; Olesen JB; Soja AM; Vilsbøll T; Kamper AL; Torp-Pedersen C; Gislason G
PLoS One; 2016; 11(2):e0148809. PubMed ID: 26863015
[TBL] [Abstract] [Full Text] [Related]
14. [Renal cell carcinoma: pathological prognostic factors, staging and histopathological classification of 355 cases].
Acosta-Jiménez E; Jerónimo-Guerrero D; Macías-Clavijo M; Rivera-Diez D; Hernández-Briseño L; Beltrán-Suárez E; Martínez-Olivares J; Ángeles-Garay U
Rev Med Inst Mex Seguro Soc; 2015; 53(4):454-65. PubMed ID: 26177433
[TBL] [Abstract] [Full Text] [Related]
15. Relationship of cd95 and COX-2 in renal cell carcinomas with survival and other prognostic parameters: A tissue microarray study.
Erdem H; Aydin HR; Bahadir A; Gündogdu B; Balta H; Sener E; Kayikci MA; Albayrak A; Erdogan F
J Pak Med Assoc; 2015 Jun; 65(6):597-601. PubMed ID: 26060153
[TBL] [Abstract] [Full Text] [Related]
16. Genetic variations in microRNAs and the risk and survival of renal cell cancer.
Du M; Lu D; Wang Q; Chu H; Tong N; Pan X; Qin C; Yin C; Wang M; Zhang Z
Carcinogenesis; 2014 Jul; 35(7):1629-35. PubMed ID: 24681820
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract] [Full Text] [Related]
18. fas expression in renal cell carcinoma accurately predicts patient survival after radical nephrectomy.
Sejima T; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
Urol Int; 2012; 88(3):263-70. PubMed ID: 22398398
[TBL] [Abstract] [Full Text] [Related]
19. The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma.
Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
Urol Oncol; 2013 Oct; 31(7):1343-9. PubMed ID: 22153754
[TBL] [Abstract] [Full Text] [Related]
20. Expression and prognostic relevance of the death receptor cd95 (fas/APO1) in renal cell carcinomas.
Macher-Goeppinger S; Bermejo JL; Wagener N; Hohenfellner M; Haferkamp A; Schirmacher P; Roth W
Cancer Lett; 2011 Feb; 301(2):203-11. PubMed ID: 21196076
[TBL] [Abstract] [Full Text] [Related]
[Next]
